Ants could be the next line of defense against cancer.
A study published in the journal Proceedings of Royal Society B: Biological Sciences focused on Ants and their keen sense of smell. Ants use smell via their thin sensory appendages that sit on top of their heads to do almost everything, including hunt for food, spotting mates, and protecting their young.
In the study, scientists used pieces of a breast cancer tumor, which were grafted onto mice, and then trained 35 ants to associate urine from the infected mice with sugar. In analyzing, scientists detected that the ants would hover for longer periods of time near the sick mouse rather than the healthy one.
Using ants to detect cancers would be a cost-cutting tool. Currently, cancers are diagnosed by blood withdrawal, biopsies, and colonoscopies, which are all considered invasive as well as being expensive procedures. Utilizing ants to screen for cancer would be significantly more reasonable.
While dogs have similar capabilities in that they are able to detect cancer in humans through smell, they take much longer to train. Baptiste Piqueret, a postdoctoral fellow at the Max Planck Institute for Chemical Ecology in Germany, said ants would be the ideal animal to use because they have good memories, are easy to train and don't bite.
Though progress has been made with ants and their cancer detection capabilities, there is still more research to be done on their efficacy. The next phase of the study will be human trials to see if ants are able to sniff out cancers through human excrement.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
